BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
GATA1
,
cell-cell adhesion
,
HIV infection
,
Breast
,
Alcohol
,
Valproic acid
,
rs3825942
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
antigen- t
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
IL2RA
TSC22D3
DUSP1
FOS
FOSB
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PUJANA_BRCA1_PCC_NETWORK
FISCHER_DREAM_TARGETS
DODD_NASOPHARYNGEAL_CARCINOMA_DN
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
LEE_BMP2_TARGETS_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
HIV integration analysis in quiescent and activated CD4 T cells
Embryonic fibroblasts transformed with alleles of SV40 large T antigen
Urothelial cell carcinoma developmental time course expression study
Mammary gland gene expression in induced-tumor growth following chronic social isolation
B-lymphocytes from PBMCs of healthy donors treated with APRIL, IFNalpha, sCD40L and SDF1
Explore Curated Studies Results
Literature
Most Relevant Literature
An Updated Review of Interleukin-2 Therapy in Cancer and Autoimmune Diseases.
Cleanup on IL-2.
Interleukin-2-induced skin inflammation.
Is There a Current Role for Combination Chemotherapy or High-Dose Interleukin 2 in Melanoma?
Location, location, location! Rewiring IL-2 circuits defines context-specific outcomes.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Isocyanate Antigens and T Cells That Cause Asthma
AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma
Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma
DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Can…
Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ